{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:14:58Z","timestamp":1793330098863,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NCI","award":["R01CA196692"],"award-info":[{"award-number":["R01CA196692"]}]},{"name":"VA CSR&D","award":["I01CX001156"],"award-info":[{"award-number":["I01CX001156"]}]}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jhep.2019.05.008","type":"journal-article","created":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T20:40:05Z","timestamp":1558989605000},"page":"523-533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":182,"title":["Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1796-8977","authenticated-orcid":false,"given":"George N.","family":"Ioannou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6438-9583","authenticated-orcid":false,"given":"Kathleen F.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2019.05.008_b0005","article-title":"Aasld guidelines for the treatment of hepatocellular carcinoma","author":"Heimbach","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.05.008_b0010","doi-asserted-by":"crossref","unstructured":"European Association For The Study Of The Liver and European Organisation For Research Treatment Of Cancer (EASL-EORTC) clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56:908\u2013943.","DOI":"10.1016\/j.jhep.2011.12.001"},{"key":"10.1016\/j.jhep.2019.05.008_b0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2019.05.008_b0020","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/MCG.0000000000000708","article-title":"Hepatocellular carcinoma surveillance among patients with cirrhosis in a population-based integrated health care delivery system","volume":"51","author":"Singal","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2019.05.008_b0025","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s11606-011-1952-x","article-title":"Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review","volume":"27","author":"Singal","year":"2012","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jhep.2019.05.008_b0030","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cgh.2007.02.039","article-title":"Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis","volume":"5","author":"Ioannou","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.05.008_b0035","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1053\/j.gastro.2015.07.056","article-title":"Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001\u20132013","volume":"149","author":"Beste","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.05.008_b0040","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.05.008_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204412","article-title":"Differences in hepatocellular carcinoma risk, predictors and trends over time according to etiology of cirrhosis","volume":"13","author":"Ioannou","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2019.05.008_b0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.05.008_b0055","unstructured":"Veterans Health Administration. Available at: http:\/\/www.va.gov\/health\/findcare.asp [Last accessed 19 December 2016]."},{"key":"10.1016\/j.jhep.2019.05.008_b0060","unstructured":"Veterans Affairs Corporate Data Warehouse. Available at: http:\/\/www.hsrd.research.va.gov\/for_researchers\/vinci\/cdw.cfm. [Last accessed on 19 December 2016]."},{"key":"10.1016\/j.jhep.2019.05.008_b0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2017.08.030","article-title":"HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma","volume":"68","author":"Ioannou","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.05.008_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2016.05.040","article-title":"Use of antibiotics among patients with cirrhosis and upper gastrointestinal bleeding is associated with reduced mortality","author":"Moon","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.05.008_b0075","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/MEG.0000000000000604","article-title":"Characteristics and outcomes of transjugular intrahepatic portosystemic shunt recipients in the VA Healthcare System","volume":"28","author":"Lerrigo","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.05.008_b0080","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1053\/j.gastro.2016.05.049","article-title":"Effectiveness of sofosbuvir, ledipasvir\/sofosbuvir, or paritaprevir\/ritonavir\/ombitasvir and dasabuvir regimens for treatment of patients with hepatitis C in the veterans affairs national health care system","volume":"151","author":"Ioannou","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.05.008_b0085","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/MEG.0000000000000290","article-title":"Associations between lipodystrophy or antiretroviral medications and cirrhosis in patients with HIV infection or HIV\/HCV coinfection","volume":"27","author":"Ioannou","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.05.008_b0090","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/hep.25800","article-title":"The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection","volume":"57","author":"Ioannou","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.05.008_b0095","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.cgh.2010.07.012","article-title":"Predictors of early treatment discontinuation among patients with genotype 1 hepatitis C and implications for viral eradication","volume":"8","author":"Beste","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.05.008_b0100","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/ajg.2010.430","article-title":"Importance of patient, provider, and facility predictors of hepatitis C virus treatment in veterans: a national study","volume":"106","author":"Kramer","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2019.05.008_b0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/hep.21662","article-title":"Predictors of response of US veterans to treatment for the hepatitis C virus","volume":"46","author":"Backus","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.05.008_b0110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-154-2-201101180-00006","article-title":"Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States","volume":"154","author":"Davila","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2019.05.008_b0115","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1053\/j.gastro.2010.12.032","article-title":"Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus Infection","volume":"140","author":"Kanwal","year":"2011","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"10.1016\/j.jhep.2019.05.008_b0120","doi-asserted-by":"crossref","first-page":"B10","DOI":"10.2337\/diacare.27.suppl_2.B10","article-title":"Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data","volume":"27","author":"Miller","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhep.2019.05.008_b0125","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2007.03572.x","article-title":"The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases","volume":"27","author":"Kramer","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2019.05.008_b0130","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.23527","article-title":"The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis","volume":"51","author":"Ascha","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.05.008_b0135","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1572-0241.2005.40670.x","article-title":"The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C","volume":"100","author":"Kramer","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2019.05.008_b0140","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/MCG.0b013e3180381560","article-title":"Utilization of screening for hepatocellular carcinoma in the United States","volume":"41","author":"Davila","year":"2007","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2019.05.008_b0145","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jhep.2017.02.027","article-title":"Effectiveness of hepatitis C antiviral treatment in a USA cohort of veteran patients with hepatocellular carcinoma","volume":"67","author":"Beste","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.05.008_b0150","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.28535","article-title":"Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection","volume":"64","author":"El-Serag","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.05.008_b0155","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1053\/j.gastro.2015.10.004","article-title":"The updated model: an adjusted serum alpha-fetoprotein-based algorithm for hepatocellular carcinoma detection with hepatitis C virus-related cirrhosis","volume":"149","author":"White","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.05.008_b0160","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2014.01.045","article-title":"A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis","volume":"146","author":"El-Serag","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.05.008_b0165","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.jhep.2019.05.008_b0170","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/biomet\/92.4.965","article-title":"Concordance probability and discriminatory power in proportional hazards regression","volume":"92","author":"Gonen","year":"2005","journal-title":"Biometrika"},{"key":"10.1016\/j.jhep.2019.05.008_b0175","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/sim.1621","article-title":"A new measure of prognostic separation in survival data","volume":"23","author":"Royston","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.jhep.2019.05.008_b0180","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0272989X9301300107","article-title":"Validation of probabilistic predictions","volume":"13","author":"Miller","year":"1993","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jhep.2019.05.008_b0185","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/(SICI)1097-0258(19990915\/30)18:17\/18<2529::AID-SIM274>3.0.CO;2-5","article-title":"Assessment and comparison of prognostic classification schemes for survival data","volume":"18","author":"Graf","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/j.jhep.2019.05.008_b0190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jclinepi.2016.05.007","article-title":"Geographic and temporal validity of prediction models: different approaches were useful to examine model performance","volume":"79","author":"Austin","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jhep.2019.05.008_b0195","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jhep.2017.07.033","article-title":"Toronto HCC risk index: a validated scoring system to predict 10-year risk of HCC in patients with cirrhosis","volume":"68","author":"Sharma","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.05.008_b0200","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.05.008_b0205","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1472-6947-8-53","article-title":"Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers","volume":"8","author":"Vickers","year":"2008","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.jhep.2019.05.008_b0210","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/biostatistics\/kxr047","article-title":"A measure of explained risk in the proportional hazards model","volume":"13","author":"Heller","year":"2012","journal-title":"Biostatistics"},{"key":"10.1016\/j.jhep.2019.05.008_b0215","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.05.008_b0220","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/hep.23615","article-title":"Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States","volume":"52","author":"Davila","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.05.008_b0225","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/j.cgh.2015.08.014","article-title":"Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice","volume":"13","author":"Singal","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.05.008_b0230","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2017.26","article-title":"Cost-effectiveness of risk score-stratified hepatocellular carcinoma screening in patients with cirrhosis","volume":"8","author":"Goossens","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jhep.2019.05.008_b0235","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/hep.28895","article-title":"An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis","volume":"65","author":"Atiq","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.05.008_b0240","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.jhep.2018.07.024","article-title":"Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C","volume":"69","author":"Ioannou","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.05.008_b0245","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/cncr.28832","article-title":"Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model","volume":"120","author":"Flemming","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.jhep.2019.05.008_b0250","unstructured":"Bruix J, Sherman M. AASLD Practice Guideline. Management of Hepatocellular Carcinoma: An Update. Available at: http:\/\/www.aasld.org\/sites\/default\/files\/guideline_documents\/HCCUpdate2010.pdf. 2011."},{"key":"10.1016\/j.jhep.2019.05.008_b0255","doi-asserted-by":"crossref","first-page":"275","DOI":"10.7326\/0003-4819-106-2-275","article-title":"Decision analysis: a progress report","volume":"106","author":"Kassirer","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2019.05.008_b0260","doi-asserted-by":"crossref","first-page":"242","DOI":"10.7326\/0003-4819-157-4-201208210-00004","article-title":"Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study","volume":"157","author":"Raji","year":"2012","journal-title":"Ann Intern Med"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827819302910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827819302910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T15:17:25Z","timestamp":1566487045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827819302910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0168827819302910"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2019.05.008","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2019.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}